In addition, when gene expression was compared in CD90+ LCSCs and pericarcinomatous tissue, CD90+ HCC cells expressed genes that contributed to inflammation and drug resistance [6], suggesting that CD90 was a more sensitive and specific marker of liver cancer stem-like cells in HCC. The gene discussed is THY1; the disease is liver cancer.